Epithelial-to-Mesenchymal Transition in Fibrosis: Concepts and Targeting Strategies
The epithelial-to-mesenchymal transition (EMT), an embryonic program relaunched during wound healing and in pathological conditions such as fibrosis and cancer, continues to gain the attention of the research community, as testified by the exponential trend of publications since its discovery in the...
Main Author: | Sara Lovisa |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.737570/full |
Similar Items
-
Role of Epithelial–Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments
by: Maria Luisa Calabrò, et al.
Published: (2020-11-01) -
Controversies over the Epithelial-to-Mesenchymal Transition in Liver Fibrosis
by: Kojiro Taura, et al.
Published: (2016-01-01) -
New Insights into the Role of Epithelial–Mesenchymal Transition during Aging
by: Francisco Santos, et al.
Published: (2019-02-01) -
The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis
by: Amani Abraheem Alsadiq Alyaseer, et al.
Published: (2020-05-01) -
Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States
by: Laura Bornes, et al.
Published: (2021-05-01)